| GROUP | Ordinary share capital R’000 |
Preference share capital R’000 |
Share premium R’000 |
Con-tingency reserve R’000 |
Share- based payment reserve R’000 |
Foreign currency translation reserve R’000 |
Treasury shares R’000 |
Retained earnings R’000 |
Non– controlling interest R’000 |
Total equity R’000 |
||||||||||
| Balance as at 30 June 2012 | 8 238 | 166 | 340 961 | 188 540 | 9 357 | (646) | (1 772) | 337 973 | 30 623 | 913 440 | ||||||||||
| Issue of share capital | 7 346 | – | – | – | – | – | – | – | – | 7 346 | ||||||||||
| Foreign exchange benefit | – | – | – | – | – | 1 900 | – | – | – | 1 900 | ||||||||||
| Share-based payment expense (note 37) | – | – | – | – | 39 868 | – | – | – | – | 39 868 | ||||||||||
| Treasury shares revalued | – | – | – | – | – | – | (552) | – | – | (552) | ||||||||||
| Reduction of contingent shares to be issued | – | – | – | (51 282) | – | – | – | – | – | (51 282) | ||||||||||
| Transfer from non-controlling interest as a result of share buy-backs | – | – | – | – | – | – | – | 2 343 | (2 343) | – | ||||||||||
| Equity arising on: | ||||||||||||||||||||
| – Consolidation of Medscheme International | – | – | – | – | – | – | – | (1 218) | – | (1 218) | ||||||||||
| – Disposal of 49% of Bonitas Marketing | – | – | – | – | – | – | – | (154) | 3 093 | 2 939 | ||||||||||
| – Acquisition of remaining 49% of IE Business | – | – | – | – | – | – | – | (6 645) | 446 | (6 199) | ||||||||||
| Dividends paid (note 36) | – | – | – | – | – | – | – | (33 219) | (4 053) | (37 272) | ||||||||||
| Net profit for the year | – | – | – | – | – | – | – | 161 670 | 22 439 | 184 109 | ||||||||||
| Balance as at 30 June 2013 | 15 584 | 166 | 340 961 | 137 258 | 49 225 | 1 254 | (2 324) | 460 750 | 50 205 | 1 053 079 | ||||||||||
| Issue of share capital (note 19) | 2 237 | _ | 184 672 | – | – | – | – | – | – | 186 909 | ||||||||||
| Redemption of share capital (note 19) | – | (166) | – | – | – | _ | – | – | – | (166) | ||||||||||
| Foreign exchange benefit | – | – | – | – | – | 83 | – | – | – | 83 | ||||||||||
| Share-based payment expense (note 37) | – | – | – | – | (38 460) | – | – | – | – | (38 460) | ||||||||||
| Reduction of contingent shares issued (note 19) | – | – | – | (137 258) | – | – | – | – | – | (137 258) | ||||||||||
| Transfer from non-controlling interest as a result of share buy-backs | – | – | – | – | – | – | – | 168 | (168) | – | ||||||||||
| Second tranche payment (note 19) | – | – | – | – | – | – | – | (26 744) | _ | (26 744) | ||||||||||
| Dividends paid (note 36) | – | – | – | – | – | – | – | (70 178) | (14 323) | (84 501) | ||||||||||
| Net profit for the year | – | – | – | – | – | – | 153 741 | 16 920 | 170 661 | |||||||||||
| Balance as at 30 June 2014 | 17 821 | – | 525 633 | – | 10 765 | 1 337 | (2 324) | 517 736 | 52 634 | 1 123 602 |